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Sex Med 2Introduction: Hydrochlorothiazide has a negative inﬂuence on penile erection but little is known about the
mechanism(s) involved.
Aims: To characterize the effects of this diuretic on mouse corpus cavernosum (CC) smooth muscle in vitro and
ex vivo.
Methods: CC strips of C57BL/6 mice (12e16 weeks old) were mounted in organ baths containing Krebs-
Henseleit solution and tissue reactivity was evaluated. Expression of genes encoding diuretic targets and
enzymes involved in penile erection were evaluated by polymerase chain reaction.
Main Outcome Measures: Stimulation-response curves to phenylephrine (10 nmol/Le100 mmol/L) or to
electrical ﬁeld stimulation (1e32 Hz) were constructed, with or without hydrochlorothiazide. Strips of CC from
mice after long-term hydrochlorothiazide treatment (6 mg/kg/day for 4 weeks) with or without amiloride
(0.6 mg/kg/day for 4 weeks) in vivo also were studied. Nitric oxide and Rho-kinase pathways were evaluated.
Results: Hydrochlorothiazide (100 mmol/L) increased the maximum response to phenylephrine by 64%
in vitro. This effect was unaffected by the addition of indomethacin (5 mmol/L) but was abolished by N(u)-nitro-
L-arginine methyl ester (100 mmol/L). Hydrochlorothiazide (100 mmol/L) potentiated electrical ﬁeld
stimulation-induced contraction in vitro, but not ex vivo. Long-term treatment with hydrochlorothiazide
increased the maximum response to phenylephrine by 60% and resulted in a plasma concentration of 500 ± 180
nmol/L. Amiloride (100mmol/L) caused rightward shifts in concentration-response curves to phenylephrine
in vitro. Long-term treatment with hydrochlorothiazide plus amiloride did not signiﬁcantly increase the
maximum response to phenylephrine (þ13%). Reverse transcriptase polymerase chain reaction did not detect the
NaCl cotransporter in mouse CC. Hydrochlorothiazide did not change Rho-kinase activity, whereas amiloride
decreased it in vitro and ex vivo (approximately 18% and 24% respectively). A 40% decrease in Rock1 expression
also was observed after long-term treatment with hydrochlorothiazide plus amiloride.
Conclusion: Hydrochlorothiazide potentiates contraction of smooth muscle from mouse CC. These ﬁndings
could explain why diuretics such as hydrochlorothiazide are associated with erectile dysfunction.
Sex Med 2016;4:e115ee125. Copyright  2016, The Authors. Published by Elsevier Inc. on behalf of the Inter-
national Society for Sexual Medicine. This is an open access article under the CC BY-NC-ND license (http://
creativecommons.org/licenses/by-nc-nd/4.0/).
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Hydrochlorothiazide (HTZ) and other thiazide diuretics are
commonly used as monotherapy or in combination with other
drugs in the treatment of arterial hypertension. Although their
primary site of action is in the kidney, the major hypotensive
effect of thiazides during long-term administration is due to
vasodilation rather than saluresis or loss of free water.1e3 Thia-
zides cause vasorelaxation in vitro and in vivo, and the mecha-
nisms proposed for this action are not related to their natriuretic
effects (inhibition of the NaCl cotransporter).4e8 For instance,e115
e116 Gagliano-Jucá et alvasodilation of the human brachial artery in vivo induced by
HTZ also occurs in patients with Gitelman syndrome, which is
characterized by the presence of a non-functional thiazide-sen-
sitive NaCl cotransporter.9 Thiazides cause alterations in ion
channel homeostasis and HTZ-induced relaxations appear to be
mediated by Ca2þ-activated Kþ channels.7,10,11 For example, the
relaxant effect of HTZ in guinea pig isolated mesenteric small
arteries was associated with a decrease in intracellular calcium
concentration ([Ca2þ]i).
7,12
Thiazide and thiazide-like diuretics can cause sexual
dysfunction in humans, especially with high doses of diuretics
and hypertension.13e19 Nitric oxide (NO) released from non-
adrenergic, non-cholinergic nitrergic nerve endings and from
the endothelium is the most important mediator of corpus cav-
ernosum (CC) smooth muscle relaxation.20 In contrast,
noradrenaline, released from adrenergic nerves, is the major
mediator of penile CC contraction.21 Thus, an imbalance
between the contractile and relaxant mechanisms of non-vascular
smooth muscle could contribute signiﬁcantly to the observed
erectile dysfunction (ED) after thiazide therapy.22AIMS
Using CC strips from mice, the effect of HTZ in vitro on the
contraction of CC smooth muscle induced by phenylephrine or
electrical ﬁeld stimulation (EFS) was investigated. Because
amiloride is often coadministered with HTZ to prevent the
occurrence of hypokalemia,23,24 its possible interaction on
HTZ effects in vitro also was evaluated. The effects of long-
term treatment in vivo with HTZ, with or without amiloride,
on the contractility of CC smooth muscle ex vivo were inves-
tigated. The involvement of the NO and the Rho-kinase
(ROCK) pathways in HTZ-induced altered CC contractility
was studied. Expression of genes encoding the main target
transporter for HTZ (NaCl cotransporter) and amiloride
(epithelial sodium channel [ENaC]) also was assessed in the
CC of mice.METHODS
Animals
Male adult (3e4 months old) C57BL/6 mice (25e30 g) were
obtained from the animal care facility of the State University of
Campinas (Campinas, SP, Brazil) and used in this study. Ani-
mals were housed in temperature-controlled facilities on a
12-hour light-and-dark cycle with food and water ad libitum. All
experimental procedures were conducted in accordance with
institutional guidelines and were approved by the ethical prin-
ciples in animal research adopted by the Brazilian College for
Animal Experimentation.
Mouse CC Preparation
The animals were rendered unconscious by inhalation of CO2
and then decapitated. The penises were surgically removed andimmediately placed in chilled Krebs solution (NaCl 118 mmol/L,
NaHCO3 25 mmol/L, glucose 5.6 mmol/L, KCl 4.7 mmol/L,
KH2PO4 1.2 mmol/L, MgSO4 1.17 mmol/L, and CaCl2
2.5 mmol/L). Cavernosal strips were obtained by dissection of
the tunica albuginea and surrounding connective tissues. Each
penis resulted in two strips, one for each CC, that were vertically
suspended between two metal hooks in 10-mL organ baths
containing Krebs solution at 37C continuously bubbled with a
mixture of 95% O2 and 5% CO2 (pH ¼ 7.4). One hook was
connected to a force transducer (ADInstruments, Colorado
Springs, CO, USA) and the other acted as a ﬁxed attachment
point. The resting tension was adjusted to 4 mN and CC
strips were allowed to equilibrate for 60 minutes.25e27 Changes
in isometric force were recorded using a PowerLab 4/30
data acquisition system (Software Chart, version 7.0;
ADInstruments).Concentration-Response Curves
Cumulative concentration-response curves for phenyleph-
rine (10 nmol/Le100 mmol/L) were constructed for the CC
strips in the absence (control) or presence of HTZ (10, 30 and
100 mmol/L) and amiloride (100 mmol/L) added 30 minutes
before phenylephrine. The NO synthase inhibitor N(u)-nitro-
L-arginine methyl ester (L-NAME; 100 mmol/L) or the
cyclooxygenases inhibitor indomethacin (5 mmol/L) was used
to evaluate any inﬂuence of NO or prostaglandins on HTZ
effects in cavernosal contractility.28e30 Each strip was used for
only one concentration-response curve. The possible phar-
macologic interaction between HTZ and amiloride in the
contractile response to phenylephrine also was evaluated by
incubating CC strips with HTZ (100 mmol/L) in the presence
or absence of amiloride (100 mmol/L). To evaluate
cholinergic-mediated relaxation, cumulative concentration-
response curves were obtained by adding acetylcholine
(ACh; 0.001e10 mmol/L) to CC strip pre-contracted with
U46619 (9,11-dideoxy-11a, 9a-epoxymethanoprostaglandin
F2a; 100 nmol/L)31 in the absence (control) or presence of
HTZ (100 mmol/L). All concentration-response data were
evaluated for ﬁt to a logistics function and non-linear
regression analysis was used to determine the parameters
maximal response and log half-maximal effective concentra-
tion (EC50) using GraphPad Prism (GraphPad Software,
San Francisco, CA, USA).Electrical Field Stimulation
For EFS experiments, CC strips were placed between two
platinum ring electrodes. EFS was carried out at 50 V for
10 seconds at a range of frequencies from 1 to 32 Hz in square-
wave pulses (1-ms pulse width) using a Grass S88 stimulator
(Astro-Med, West Warwick, RI, USA). Frequency-response
curves to EFS were constructed to evaluate changes in basal
tone of strips to EFS in the absence and presence of L-NAME
(100 mmol/L) and/or HTZ (100 mmol/L).Sex Med 2016;4:e115ee125
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were pretreated with guanethidine (30 mmol/L) and atropine
(1 mmol/L) to remove the effects of adrenergic and cholinergic
neurons, respectively, and then contracted with U46619 (100
nmol/L). After stable contraction levels were attained, a series of
EFS-induced relaxations were constructed (1e32 Hz) in the
absence and presence of HTZ (100 mmol/L).21,25Long-Term Treatments
Long-term treatments were carried out by adding drugs to the
drinking water. HTZ was administered at a dose of 50 mg/L to
provide a daily intake of approximately 6 mg/kg for 4 weeks.
This dose was chosen after testing several dose regimens and
aiming for a mean plasma concentration similar to the maximum
concentration achieved after a single oral dose of HTZ 25 mg in
humans. Amiloride was added to achieve a daily dosage of
0.6 mg/kg.HTZ Plasma Determination by Tandem Mass
Spectrometry
Animals were anesthetized with isoﬂurane inhalation (5%)
and 1 mL of blood was collected by abdominal aorta puncture.
Plasma was obtained by centrifugation of blood samples at
2,000  g for 10 minutes and kept frozen at 20C until
quantiﬁcation. Plasma HTZ concentration was determined by
high-performance liquid chromatography coupled to tandem
mass spectrometry using chlortalidone as the internal standard.32
The mass spectrometer (Quattro Micro; Waters Micromass,
Milford, MA, USA), equipped with an electrospray source
running in negative mode (ES), was set up in multiple reaction
monitoring of transitions from 295.8 to 77.7 for HTZ.
Data were acquired by MassLynx 4.0 SP4 (Waters
Micromass).Reverse Transcriptase Polymerase Chain Reaction
Analysis
Isolation and puriﬁcation of CC and kidney total RNA were
performed with TRIzol reagent according to the manufacturer’s
instructions (Life Technologies, Carlsbad, CA, USA). RNA
concentration and quality were determined spectrophotometri-
cally and by electrophoresis in 1.2% non-denaturing agarose gels.
Synthesis of cDNA was performed using M-MLV reverse tran-
scriptase (200 U/mL; Promega, Madison, WI, USA). A negative
control (a reaction that did not contain the RT enzyme) was
carried out in parallel with each retro-transcription. Polymerase
chain reaction (PCR) ampliﬁcations were carried out in 50 mL of
ﬁnal volume using 1 to 2 mL of cDNA as a template. The
primers used for this experiment are listed in Table S1. The gene
HPRT, which encodes the enzyme hypoxanthine-guanosine
phosphoribosyltransferase, was chosen as the endogenous stan-
dard for RT-PCR. Ampliﬁcations were performed using
AmpliTaq Gold Master Mix (Applied Biosystems, Foster City,
CA, USA). PCR products were separated by electrophoresis inSex Med 2016;4:e115ee1251% (w/v) agarose gels and visualized under ultraviolet light after
ethidium bromide staining.Total ROCK Activity
Corpora cavernosa from untreated animals were homogenized
in a buffer solution containing Tris-HCl 20 mmol/L (pH ¼ 7.5),
NaCl 150 mmol/L, ethylenediaminetetraacetic acid 1 mmol/L,
ethylene glycol tetraacetic acid 1 mmol/L, Triton X-100 1%, and
a protease cocktail inhibitor diluted 1:2,500 (P8340; Sigma, St
Louis, MO, USA). Then, homogenates were centrifuged at
12,000  g at 4C for 10 minutes and the supernatant was used
in the assays. Each reaction contained total protein 30 mg and
adenosine triphosphate 0.1 mmol/L. Total ROCK activity was
evaluated with the CycLex Rho-Kinase Assay Kit (MBL Interna-
tional, Nagoya, Japan) according to the manufacturer’s
instructions. To evaluate the direct effects of HTZ and amiloride
on ROCK activity, the reaction was allowed to occur for
30 minutes in the presence of HTZ (100 mmol/L), amiloride
(100 mmol/L), HTZ plus amiloride (both 100 mmol/L), or ROCK
inhibitor Y-27632 (10 mmol/L). The effect of long-term treat-
ment on ROCK activity was assessed using CC from control and
regularly treated mice. The experimental procedure was per-
formed similarly to that previously described, except that the
reaction medium did not contain any diuretic or inhibitor.Quantitative PCR Analyses
Each biological sample used in the quantitative PCR experi-
ments corresponded to a pool of CC from three to four mice.
Total RNA was extracted from frozen CC of control and regu-
larly treated mice using TRIzol reagent (Life Technologies)
according to the manufacturer’s instructions. RNA concentration
and purity were determined by a Nanodrop 2000c spectropho-
tometer (Thermo Scientiﬁc, Waltham, MA, USA), and RNA
integrity was checked by electrophoresis in 1.2% non-denaturing
agarose gels.
Total RNA (1.5 mg) was checked for DNA contamination by
conventional PCR and then retro-transcribed with Superscript
III (200 U/mL; Invitrogen, Carlsbad, CA, USA) using 100 pmol
of random hexamers for priming. Subsequent ampliﬁcations
were performed in a StepOne Plus real-time detection system
(Applied Biosystems) using the SYBR Green PCR master mix
(Applied Biosystems). The following genes were analyzed: Rock1
(which encodes ROCK1), Rock2 (ROCK2), Nos1 (nitrergic
nitric oxide synthase), Nos3 (endothelial nitric oxide synthase),
Gucy1a3 (soluble guanylate cyclase), Pde5a (phosphodiesterase
type 5), and Prkg1 (protein kinase G). The constitutive HPRT
gene was used as the endogenous standard. Primers used in this
work are listed in Table S1.Materials
ACh, amiloride, atropine, HTZ, indapamide, indomethacin,
L-NAME, phenylephrine, U46619, and guanethidine were
obtained from Sigma. U46619, ACh, amiloride, atropine,
e118 Gagliano-Jucá et alguanethidine, KCl, L-NAME, and phenylephrine were dissolved
in water, and the other drugs were dissolved in ethanol. The
CycLex Rho-Kinase Assay Kit was used.
Statistical Analysis
All data are expressed as mean ± standard error mean. Instat
(GraphPad) was used for statistical analysis. Analysis of variance
for repeated measurements was performed for the results and the
Bonferroni method was chosen as the post-test. Student unpaired
t-tests were used when appropriate. A P value less than .05 was
considered signiﬁcant. EC50 values are presented as their negative
logarithm (pEC50).MAIN OUTCOME MEASURES
The main outcome measurement of this study was the gen-
eration of stimulation-response curves to assess whether thiazide
diuretics had any effect on the contractility of mouse CC. Once
observed that this class of diuretics, especially HTZ, had a dra-
matic impact on isolated CC contractility, the involvement of
NO and ROCK pathways was also investigated.Figure 1. Response curves of mouse corpus cavernosum smooth mu
addition of PE to corpus cavernosum strips alone (control) or after pre
of PE to corpus cavernosum strips alone or after pre-incubation with
methacin. Panel C shows the addition of PE to corpus cavernosum st
(100 mmol/L), or HTZ plus L-NAME. Panel D shows contractile respons
Hz) in the absence (control) or presence of HTZ (100 mmol/L). PE wa
values were calculated by subtracting the basal tone from maximal c
ulation. Data are presented as mean ± standard error of the mean of
evaluated. HTZ ¼ hydrochlorothiazide; L-NAME ¼ N(u)-nitro-L-arginRESULTS
Effects of HTZ on Contractions to Phenylephrine
The cumulative addition of phenylephrine (10 nmol/Le10
mmol/L) induced concentration-dependent contractions of the
mouse CC smooth muscle. HTZ (10e100 mmol/L; n ¼ 4)
caused a signiﬁcant increase of concentration-dependent
contractions to phenylephrine compared with those to phenyl-
ephrine alone (control group; Figure 1A, Table 1). Indomethacin
(5 mmol/L; n ¼ 7) caused a signiﬁcant rightward shift in the
concentration-response curves to phenylephrine compared with
the control group (Figure 1B, Table 2) but did not affect the
HTZ-induced leftward shift in the concentration-response curves
to phenylephrine (Figure 1B, Table 2).
The addition of L-NAME (100 mmol/L, n ¼ 7) caused an
augmented maximum response and a leftward shift in
phenylephrine-induced contractions (Figure 1C, Table 2).
Addition of HTZ (100 mmol/L; n ¼ 7), in the presence
of L-NAME failed to change the contractions induced by
phenylephrine in CC strips compared with L-NAME
alone (Figure 1C, Table 2). The addition of HTZ to the Krebsscle strips to PE and electrical ﬁeld stimulation. Panel A shows the
-incubation with HTZ (10e100 mmol/L). Panel B shows the addition
HTZ (100 mmol/L), indomethacin (5 mmol/L), or HTZ plus indo-
rips alone or after pre-incubation with HTZ (100 mmol/L), L-NAME
es of mouse corpus cavernosum to electrical ﬁeld stimulation (1e32
s used at concentrations of 10 nmol/L to 100 mmol/L. Contraction
ontractions (milli-newtons) produced by PE or electrical ﬁeld stim-
four to eight experiments. *P < .05 vs control for each frequency
ine methyl ester; PE ¼ phenylephrine.
Sex Med 2016;4:e115ee125
Table 1. pEC50 and Emax obtained from concentration-response
curves to phenylephrine (10 nmol/Le100 mmol/L) with and without
diuretics in mouse corpus cavernosum smooth muscle*
Phenylephrine
pEC50 Emax (mN) Experiments, n
Control 6.20 ± 0.15 0.44 ± 0.05 8
HTZ 10 mmol/L 6.31 ± 0.11 0.54 ± 0.06 6
HTZ 30 mmol/L 6.56 ± 0.04 0.69 ± 0.02† 4
HTZ 100 mmol/L 6.37 ± 0.11 0.72 ± 0.07‡ 7
Control 6.04 ± 0.03 0.44 ± 0.05 7
Amiloride 100
mmol/L
5.46 ± 0.07‡ 0.44 ± 0.05 4
Control 5.54 ± 0.16 0.53 ± 0.04 5





4.94 ± 0.12† 0.53 ± 0.04k 13
Control 6.33 ± 0.10 0.48 ± 0.06 10
Long-term HTZ
(6 mg/kg/d)
6.38 ± 0.11 0.77 ± 0.10† 4
Control 6.10 ± 0.15 0.47 ± 0.07 5
Long-term HTZ
þ amiloride
6.14 ± 0.17 0.53 ± 0.07 5
Emax ¼maximal response; HTZ ¼ hydrochlorothiazide; pEC50 ¼ potency at
half-maximal effective concentration.
*Data presented as mean ± standard error of the mean of the number of
experiments. pEC50 is represented as the negative logarithm of molar con-
centration to produce 50% of maximal contractile response elicited by the
agonist relative to phenylephrine-induced contractions. Emax is calculated as
milli-newtons of contraction relative to the maximal changes from the
contractile response produced by phenylephrine.
†P < .05 vs control group; ‡P < .01 vs control group; kP < .05 vs HTZ group.
Table 2. pEC50 and Emax obtained from concentration-response
curves to phenylephrine (10 nmol/Le100 mmol/L) with and without
HTZ (100 mmol/L), L-NAME, and indomethacin in mouse
cavernosal smooth muscle*
Phenylephrine
pEC50 Emax (mN) Experiments, n
Control 6.24 ± 0.14 0.46 ± 0.02 7
L-NAME 100
mmol/L
6.89 ± 0.14‡ 0.65 ± 0.05† 7
†
Hydrochlorothiazide Potentiates Cavernosal Contractile Activity e119solution before phenylephrine did not result in changes to the




6.79 ± 0.16† 0.60 ± 0.04† 7
Control 6.25 ± 0.14 0.46 ± 0.02 5
Indomethacin 5
mmol/L
5.69 ± 0.11† 0.48 ± 0.02 7
†Effects of HTZ on Relaxation to ACh
In contrast to its clear modulation of contractions, HTZ did
not affect relaxations induced by ACh on CC strips pre-
contracted with U46619 (100 nmol/L; EC50 ¼ 7.26 ± 0.29




6.19 ± 0.05§ 0.60 ± 0.05†,§ 7
Emax ¼ maximal response; HTZ ¼ hydrochlorothiazide; L-NAME ¼ N(u)-
nitro-L-arginine methyl ester; pEC50 ¼ potency at half-maximal effective
concentration.
*Data presented as mean ± standard error of the mean of the number of ex-
periments. pEC50 is representedas thenegative logarithmofmolar concentration
to produce 50%ofmaximal contractile response elicited by an agonist relative to
phenylephrine-induced contractions. Emax is calculated as milli-newtons of
contraction relative to the maximal changes from the contractile response
produced by phenylephrine.
†P < .05 vs control group; ‡P < .01; §P < .05 vs indomethacin group.Effects of HTZ on Responses to EFS
Under control conditions, the CC strips responded to EFS
with frequency-dependent contractions. Exposure of CC strips to
HTZ (100 mmol/L, n ¼ 7) for 30 minutes before and during
EFS increased the contractile responses (Figure 1D). L-NAME
(100 mmol/L, n ¼ 7) increased the contraction to EFS and HTZ
could no longer potentiate these responses (as observed with
phenylephrine-induced contractions).
In CC strips pre-contracted with U46619 (100 nmol/L;
n ¼ 7; 0.39 ± 0.04 and 0.37 ± 0.04 mN, for control and HTZ,Sex Med 2016;4:e115ee125respectively), EFS elicited frequency-dependent relaxations that
were unaffected by the addition of HTZ (100 mmol/L).Effects of Long-Term Treatment In Vivo With HTZ
on CC Strips and Response Ex Vivo
The CC strips prepared from mice receiving HTZ (6 mg/kg/
day) for 4 weeks showed a signiﬁcant change in maximal
response to phenylephrine and a substantial decrease of
EFS-evoked relaxations (Figure 2A and B, Table 1). No effect
was observed on relaxations induced by ACh on CC strips pre-
contracted with U46619 100 nmol/L (EC50 ¼ 7.33 ± 0.13 and
7.38 ± 0.16 for control and treatment, respectively; n ¼ 5).HTZ Plasma Concentration on Long-Term
Treatment
The HTZ plasma concentration from mice receiving HTZ
(6 mg/kg/day) in the drinking water at the end of treatment was
149 ± 56 ng/mL (500 ± 180 nmol/L; n ¼ 6).Amiloride Attenuation of HTZ-Induced Potentiation
of CC Contractility In Vitro
Amiloride (100 mmol/L, n ¼ 4) signiﬁcantly attenuated the
phenylephrine-induced CC contractions compared with the
corresponding control group (Figure 3A, Table 1).
Figure 2. Concentration-response curves of mouse corpus cavernosum smooth muscle strips to PE and relaxant response to electrical
ﬁeld stimulation after long-term administration of HTZ in vivo. Panel A shows the addition of PE to corpus cavernosum strips from
untreated (control) and HTZ-treated mice. Panel B shows the relaxant responses to electrical ﬁeld stimulation (1e32 Hz) in untreated
(control) and HTZ-treated animals. *P < .05 vs control for each frequency evaluated. PE was used at concentrations of 10 nmol/L to 100
mmol/L. Contraction values were calculated by subtracting the basal tone from maximal contractions (milli-newtons) produced by PE or
electrical ﬁeld stimulation. Data are presented as mean ± standard error of the mean of 4 to 10 experiments. HTZ ¼ hydrochlorothiazide;
PE ¼ phenylephrine.
e120 Gagliano-Jucá et alPre-incubation of CC strips with amiloride plus HTZ (100
mmol/L for both; n ¼ 13) reversed the increase in maximal
response observed with HTZ alone (100 mmol/L; n ¼ 8)
compared with the control. The rightward shift previously
observed with amiloride alone was maintained even in the
presence of HTZ (Figure 3B, Table 1).Effects of Long-Term Treatment In Vivo With HTZ
Plus Amiloride on CC Strips and Response In Vitro
Changes inmaximal response to phenylephrine and reduction of
EFS-evoked relaxations were not observed in CC strips prepared
from mice receiving HTZ plus amiloride (6 mg/kg/day and 0.6
mg/kg/day, respectively) over 4 weeks (Figure 4A and B, Table 2).
Moreover, regular treatment did not affect Ach-induced relaxations
of CC strips pre-contracted with U46619 (EC50 7.7 ± 0.11 and
7.8 ± 0.2 for control and treatment respectively, n ¼ 5).Figure 3. Concentration-response curves of mouse corpus cavernos
shows the addition of PE to corpus cavernosum strips alone (control)
addition of PE to corpus cavernosum strips alone and after pre-inc
concentrations of 10 nmol/L to 100 mmol/L. Contraction values were c
(milli-newtons) produced by PE. Data are presented as mean ± standar
hydrochlorothiazide; PE ¼ phenylephrine.NaCl Cotransporter and ENaC Expression
Transcription of the Scnn1a gene, which encodes the a sub-
unit of the ENaC, a known target of amiloride, was readily
detected in mouse CC. However, Slc12a3 gene transcripts,
encoding the thiazide sensitive NaCl cotransporter, could not be
ampliﬁed (n ¼ 2; Figure 5).Diuretic-Induced Changes in ROCK Activity
Amiloride inhibitedROCK activity in vitro alone (82± 3.7%of
control activity; n ¼ 6; P < .01; Figure 6A) or with HTZ
(78± 3.8% of control activity; n¼ 6; P< .001). After incubation
with ROCK inhibitor Y-27632, total activity was decreased to 28
± 1.5%. Treatment of mice for 4 weeks with HTZ plus amiloride
decreased total ROCK activity ex vivo (76 ± 5.3%; Figure 6B)
compared with the control group (n ¼ 7; P < .01). The ROCK
activation assay did not detect any inﬂuence of HTZ on ROCKum smooth muscle strips to PE in the presence of Am. Panel A
and after pre-incubation with Am (100 mmol/L). Panel B shows the
ubation with HTZ (100 mmol/L) or HTZ þ Am. PE was used at
alculated by subtracting the basal tone from maximal contractions
d error of the mean of 4 to 13 experiments. Am ¼ amiloride; HTZ ¼
Sex Med 2016;4:e115ee125
Figure 4. Concentration-response curves of mouse corpus cavernosum smooth muscle strips to PE and relaxant response to electrical
ﬁeld stimulation after long-term coadministration of HTZ and amiloride in vivo. Panel A shows the addition of PE to corpus cavernosum
strips from untreated mice (control) and mice treated with HTZ plus amiloride. Panel B shows relaxant responses to electrical ﬁeld
stimulation (1e32 Hz) in untreated mice (control) and mice treated with HTZ plus amiloride. PE was used at concentrations of 10 nmol/L to
100 mmol/L. Contraction values were calculated by subtracting the basal tone from maximal contractions (milli-newtons) produced by PE or
electrical ﬁeld stimulation. Data are presented as mean ± standard error of the mean of ﬁve experiments. CTL ¼ control; HTZ ¼ hy-
drochlorothiazide; PE ¼ phenylephrine.
Hydrochlorothiazide Potentiates Cavernosal Contractile Activity e121activity acutely in vitro (92 ± 3.7% of control activity; n ¼ 6;
P > .05; Figure 6A) or ex vivo after long-term treatment
(89 ± 7.0% of control activity; n ¼ 7; P > .05; Figure 6B).Quantitative RT-PCR
Quantitative real-time PCR was used to analyze any possible
effect of HTZ or HTZ plus amiloride treatment on the
expression of genes encoding proteins involved in penile erection.
No alteration in Rock1, Rock2, Nos1, Nos3, Gucy1a3, or Pkrg1
transcripts levels was observed in HTZ-treated mice compared
with the control group, whereas a 20% decrease was observed for
Pde5a transcripts. However, long-term treatment with amiloride
plus HTZ produced 40% and 55% downregulation of Rock1
and Nos1 gene expression, respectively (Table 3).DISCUSSION
Our results have clearly demonstrated that HTZ potentiates
phenylephrine-induced and EFS-induced contractions of mouseFigure 5. RT polymerase chain reaction with cDNA from mouse
tissues (n ¼ 2). Reactions were produced with (þ) and without ()
RT. The genes (corresponding encoded proteins) under study
appear below the respective gels. CC ¼ corpus cavernosum;
ENaC ¼ epithelial sodium channel; K ¼ kidney; NCC ¼ NaCl
cotransporter; RT ¼ reverse transcriptase.
Sex Med 2016;4:e115ee125CC strips in vitro. This effect also was observed ex vivo after
long-term treatment with HTZ. This action appeared to be
speciﬁc to thiazide-like diuretics, because the same effect was
obtained with indapamide (Figure S1) but was not observed with
the potassium-sparing diuretic amiloride. This effect is not
related to the known target of HTZ, the NaCl cotransporter
(Slc12A3 gene), because RT-PCR did not detect its expression in
mouse CC. This is the ﬁrst report of HTZ-induced potentiation
of CC contractility, which could explain the association of ED
with thiazide-based therapies. This conclusion, although robust,
might be further strengthened by an in vivo assessment of erectile
function after HTZ treatment that additional studies should
address. Smooth muscle tone and agonist-elicited responses are
inﬂuenced by levels of endogenous cyclooxygenase
products.33e35 Inhibition of cyclooxygenases by diclofenac
(50 mg) or rofecoxib (25 mg) signiﬁcantly decreases the diuretic-
natriuretic effect of HTZ in humans, indicating a possible role
for prostaglandins in the renal effects of thiazides.36 Indometh-
acin potentiated ACh-induced relaxation of the rabbit CC,
indicating the presence of contractor cyclooxygenase products.37
This would be compatible with our results in which indometh-
acin caused a rightward shift of phenylephrine-induced con-
tractions, strongly suggesting the loss of a contractor
cyclooxygenase product. However, HTZ could still potentiate
phenylephrine-induced contractions of indomethacin-treated
CC strips, ruling out a mechanism based on cyclooxygenase
products as an explanation of HTZ-induced potentiation.
Inhibition of NO biosynthesis increases contractile responses
in many smooth muscle preparations.38e40 However, thiazide
diuretics did not potentiate ACh-induced relaxations of rat aorta,
indicating that their action on blood vessels can be independent
of NO release.41 Interestingly, in our experiments, HTZ failed to
potentiate phenylephrine-induced contractions in the presence of
the NO synthesis inhibitor L-NAME in vitro, suggesting an
Figure 6. Evaluation of ROCK activity. Panel A shows the inﬂuence of HTZ (100 mmol/L), Am (100 mmol/L), HTZ þ Am, and Y-27632 on
ROCK activity, expressed as the mean percentage of control ± standard error of the mean. Control ¼ 100 ± 4.0; HTZ ¼ 92 ± 3.7; HTZ þ
Am ¼ 78 ± 3.8; Am ¼ 82 ± 3.7; Y-27632 ¼ 28 ± 1.5. *P < .01 vs control group; †P < .001 vs control group; n ¼ 6 for all groups. Panel B
shows total ROCK activity, expressed as mean percentage ± standard error of the mean compared with the control group. Control ¼ 100 ±
5.7%; HTZ ¼ 89 ± 7.0%; HTZ þ Am ¼ 76 ± 5.3%. *P < .01 vs control group; n ¼ 7 for all groups. Am ¼ amiloride; HTZ ¼ hydro-
chlorothiazide; ROCK ¼ Rho-kinase.
e122 Gagliano-Jucá et alinvolvement of the NO pathway in this potentiation. However,
HTZ affected neither the relaxation induced by ACh nor that
induced by EFS in mouse CC in vitro, ruling out NO
involvement in its action. One possible explanation is that the
leftward shift caused by NO inhibition “overrides” other
mechanisms, because of the major role of NO as the relaxation
agent in this tissue.
After regular treatment with HTZ for 4 weeks, potentiation of
phenylephrine-induced contractionwas observed ex vivo, similarly
to the in vitro response to the addition of HTZ, indicating an
adaptive response of CC to HTZ. The CC contractile response to
EFS was similar to the control after long-term treatment with
HTZ, diverging from the different responses observed in vitro.
These changes in EFS response patterns after long-term treatment
could result from adaptations that might compensate one another.
An increase of adrenergic sensitivity as a whole could explain this
result. In fact, when using phenylephrine only, the a1-adrenergicTable 3. Abundance of transcripts of Rock1, Rock2, Nos1, Nos3,
Gucy1a3, Pde5a, and Prkg1 in mouse corpora cavernosa*
Fold change in gene expression
Gene name Control group HTZ group HTZ þ Am group
Rock1 1.01 ± 0.11 1.11 ± 0.15 0.61 ± 0.06†
Rock2 1.02 ± 0.15 0.91 ± 0.29 1.0 ± 0.19
Nos1 1.0 ± 0.09 0.8 ± 0.19 0.45 ± 0.1†
Nos3 1.0 ± 0.05 1.08 ± 0.13 0.87 ± 0.06
Gucy1a3 1.0 ± 0.08 0.97 ± 0.23 0.93 ± 0.16
Pde5a 1.0 ± 0.04 0.79 ± 0.01† 0.98 ± 0.12
Prgk1 1.0 ± 0.05 0.91 ± 0.06 0.99 ± 0.22
Control ¼ untreated mice; HTZ ¼ mice treated with hydrochlorothiazide;
HTZ þ Am ¼ mice treated with hydrochlorothiazide plus amiloride.
*Messenger RNA levels were analyzed by quantitative real-time polymerase
chain reaction and normalized in relation to those of the HPRT gene.
Average values ± standard error of the mean of three independent biological
replicas are represented.
†P < .05 vs control group.response is observed. In contrast, when EFS stimuli are used, a1-
and b3-adrenoceptors are stimulated simultaneously. The b3-
adrenoceptors relax humanCC in vitro by inhibition of the ROCK
pathway42; thus, the increase in sensitivity of these two antago-
nistic pathways would result in an unchanged contractile response.
However, this explanation is not supported by our results, because
we did not ﬁnd a signiﬁcant diminution of ROCK activity after
long-term treatment with HTZ.
Thiazide diuretics attenuate agonist-induced vasoconstriction
in vivo and in vitro by calcium desensitization of vascular smooth
muscle cells, which is linked to the RhoA-Rho kinase pathway.43
The expression of RhoA in rabbit CC is 17-fold higher that in
ileum smooth muscle, and inhibition or stimulation of this
pathway directly affects erectile function.44,45 In our experi-
ments, HTZ failed to potentiate total ROCK activity in vitro
and long-term treatment with HTZ did not inﬂuence the
expression of Rock1 and Rock2 or total ROCK activity. Further,
stimulation of the ROCK pathway decreases endothelial NO
synthase activity and expression,45,46 which was not observed in
this study, corroborating the unchanged response to ACh-
induced relaxation observed in the ex vivo experiments.
Long-term HTZ treatment resulted in decreased EFS-induced
relaxation diverging from the similar relaxation observed in vitro.
This decrease cannot be explained by modiﬁcations in the
expression of Nos1, Gucy1a3, or Prkg1, because the transcrip-
tion level of these genes was unaltered in the HTZ group.
These results could be clinically important, because ED has
been reported after in vivo treatment with thiazides.13e18 From
the preceding discussion, it is likely that contraction of the non-
vascular smooth muscle of the CC could compromise the effects
of any vasodilatation and thus weaken the erectile response. The
concentration of HTZ achieved therapeutically, approximately
130 ng/mL after ingesting a 25-mg tablet, is close to that found
to potentiate ex vivo the phenylephrine-induced contractions of
mouse CC.32 Long-term exposure to this concentration in vivo
resulted in an increase of approximately 50% of the maximalSex Med 2016;4:e115ee125
Hydrochlorothiazide Potentiates Cavernosal Contractile Activity e123response to phenylephrine ex vivo. It is relevant to note that the
ED caused by HTZ is more evident with higher doses of the
diuretic.15,18
Transcripts of the main target of amiloride, the ENaC, were
detected in mouse CC by RT-PCR. This ﬁnding is interesting
because amiloride caused an attenuation of phenylephrine-
induced contraction, even in the presence of HTZ. In vascular
smooth muscle, ENaC is considered a mediator in the regulation
of pressure-induced vasoconstriction.47,48 Usually, amiloride is
not used clinically as a single agent; therefore, there are no clear
data available on their effects on erectile function. In the present
work, amiloride inhibited total ROCK activity in vitro and
ex vivo. This inhibition could explain why amiloride reversed the
HTZ-induced potentiation of CC contractility to phenylephrine.
The precise molecular mechanism by which amiloride exerts this
effect is not fully understood. However, our results show a
downregulation of Rock1 gene expression after long-term ami-
loride plus HTZ treatment, suggesting the involvement of an
unidentiﬁed transcriptional regulator.
Consistent with the attenuation of phenylephrine-induced
contraction, long-term treatment with amiloride plus HTZ
also reversed the decreased EFS-induced relaxation observed with
HTZ alone. This observation is surprising considering the
twofold downregulation of Nos1 gene expression found in the
HTZ plus amiloride group. However, despite the unchanged
Pde5a expression levels, it cannot be ruled out that a counter-
acting decrease in phosphodiesterase type 5 activity occurs.
Overall, these observations suggest that coadministration of
amiloride in patients who develop HTZ-induced ED might
ameliorate this adverse effect. However, more studies are needed
to support this hypothesis.
CONCLUSION
In this work, we clearly demonstrate that HTZ in vitro and
after exposure in vivo with concentrations achieved therapeuti-
cally potentiates CC smooth muscle contraction. This effect is
not mediated by the NaCl cotransporter or by activation of the
ROCK pathway. An increased adrenergic response or sensitivity
and decreased NO-mediated relaxation could play a major role in
this phenomenon. However, the elucidation of the precise
mechanisms requires further investigation. These ﬁndings could
explain why HTZ is associated with ED in humans.Corresponding Author:Mauro Napolitano, PhD, Department
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